Page 55 - GMP for warehouse
P. 55

GMP Training – GMP for Warehouse by www.gmpsop.com


               Step 1: Defective product in the market
               In the event of a recall, QA will agree with the regulators on the scope of the
               recall before the recall is triggered. The recall decision will usually happen very
               quickly, so the warehouse must be recall-ready at all times. The company should
               assess the quantity of stock in the marketplace at this time, with the aim of
               recovering 100% of available stock.


               Step 2: Recall notice Issued
               The recall notice will state that the recall must occur at a particular level in the
               marketplace. Class I recalls occur at the consumer level; Class II or III recalls
               may occur at the retail or warehouse level. For consumer level recalls, there is
               usually a company hotline to assist customers.

               Step 3: Return to company locations

               Defective product will be collected at nominated warehouses. It is progressively
               checked, counted, and the returns recorded in a recall register. As the recall
               progresses,  the  percentage  of  defective  stock  is  monitored.  The  recall  is
               continued until 100% is returned, if possible.

               Step 4: Move to dedicated Recall store
               The detective product is eventually gathered in one central location in a separate,
               secure Recall store or location. The recalled material must never end up in the
               main warehouse.


               Step 5: Destruction
               Once the recalled product has been secured, it should be securely destroyed so
               that there is no possibility it ends up back in the marketplace. Companies should
               have  secure  destruction  procedures,  and  the  physical  destruction  should  be
               witnessed or otherwise verified.


               Counterfeit products

               Unfortunately, it has become prevalent for counterfeit medicines to make their
               way into the distribution chain. Many of these products look almost identical to
               the original products, both in drug appearance and packaging, These counterfeit
               products contain no active ingredients (APIs), and can be dangerous to patient

               health if consumed. They may even contain poisons.

                                         Copyright©www.gmpsop.com. All rights reserved
                Unauthorized copying, publishing, transmission and distribution of any part of the content by electronic means are strictly prohibited.
                                                         Page 55 of 64
   50   51   52   53   54   55   56   57   58   59   60